Nonetheless, HT-EA investigated in this study resulted in the regulation of therapy-associated increased localization of β-catenin, KI-67, NKX3.2, GRB10, Megf10, PhPT-1, and MMP-9 in residual PC models. This evidence concerns the gene MEGF10 and pachyonychia congenita.